LIPIDOL

Emulsifier, EU registered and is considered a generally permitted additive with no species or dose restriction
Surfactant, Engineered to be the most effective, most concentrated, and thermally stable in-feed fat emulsifier
and Nutrient With surfactant properties of phospholipids, making it a better oil-in-water emulsifier
Potentiator Increases digestibility of fat in the diet, making it readily available for animal utilization
Improves feed conversion ratio and animal performance
Aids in extracting maximum nutrient value from every kilo of diet by altering permeability of cell
membrane
Has shown to work in dairy cattle, pigs, intensively fattened sheep, turkeys, broilers, and layers
No colorants, preservatives, and stabilizers added

Product Lysophospholipid (mol% of lipid fraction)

Specification LPC 6.2% min
LPI 1.7% min
LPE 2.5% min
LPA 1.0% min
Total 11.0% min

Dosage: 0.52.0 kg/ ton of feed

Packing: 25 kg multiwall kraft bag
Shelf Life: 12 months
Physical Appearance: Off-white free-flowing powder

Active Lipid Weight Typical Lipidol Profile Typical Emulsifier Profile

Comparison (Weight %) (Weight %)
with Other 1-LPC (1-Lysophosphatidylcholine) 0.15 0.00
Emulsifiers 2-LPC (2-Lysophosphatidylcholine) 1.53 1.26
LPI (Lysophosphatidylinositol) 0.84 0.54
LPE (Lysophosphatidylethanolamine) 0.92 0.95
LPA (Lysophosphatidic acid) 0.24 0.32
Total Lysolipids 3.68 3.07
Lipidol and typical emulsifier results taken from blind test of random samples carried out by European
customer by Spectral Service GmbH.

Pathway Intermediates LIMITED is a private limited company established in 2001. Its primary purpose is to provide
research input and innovation to the bioscience industry, with emphasis on animal health. It also produces feed additives
with manufacturing processes that follow UFAS and FEMAS standards, hence providing the highest quality of products
with consistency.
Pathway Intermediates has particular interest and expertise in the area of biofunctional glycerides, fatty acids,
structured lipids, and phospholipids. Understanding the biology and the chemistry of these compounds forms the
foundation for all its products. Facilitating their natural activities or where necessary, modifying them for todays intensive
demands, defines the business of Pathway Intermediates.

Address: Unit 1, The Green Industrial Estate, Clun, Shropshire SY7 8LG United Kingdom
Telephone: +44 (0)1584 875550 Facsimile: +44(0)1584 875572
Web: http://morebetterdifferent.co.uk/~pathway/ Email: office@pathway-intermediates.com
 Swine Piglet Trial through Devenish Nutrition
Trial Summary Energy Sparing Effect of
Lipidol

Growth rate (g/d)

Age of pigs: Weaning at 28

FCR
days post weaning
No. of pigs: 24 per
treatment
Treatments: Control;
Less 10 kg oil with 0.75 kg Treatment
Treatment
Lipidol; Less 60 kcal/kg ME
with 0.75 kg Lipidol

Dosage Trial on Piglets

Liveweight gain in nursery pigs-fed lysolecithins ADG at 35 days (g)

Overall, Lipidol improves ADG linearly (P=0.04) between

Day 15 and Day 35 in pigs.
Dietary lysolecithin at 0.02% improves digestibility of fat
(P=0.10), DM (P=0.003) and protein (P=0.001).

Lysolecithins (% diet)

POULTRY Typical Results: 3%7% improvement in FCR

Trial Summary Control Treated % Improvement
Belgium 93 100 birds 1.69 1.60 5.3%
Belgium 93 100 birds 1.92 1.65 14.1%
Netherlands 2 6 reps 12 birds 1.65 1.63 1.2%
UK 94 36,000 birds 1.91 1.79 6.1%
Czech 95 26,000 birds 2.06 1.98 3.9%
Czech 95 80,000 birds 2.20 2.05 6.8%
Belgium 2 14 reps 30 birds 1.81 1.75 3.3%
UK 2000 2 8 reps 50 reps 1.26 1.18 6.4%
UK 2001 2 8 reps 74 birds 1.28 1.23 3.4%

Typical Results: 30%50% reduction in Mortality

Control Treated % Reduction
Belgium 93 100 birds 4.00 2.00 50%
Netherlands 2 6 reps 12 birds 3.30 1.70 48%
UK 94 36,000 birds 6.83 4.63 32%